Zacks Investment Research upgraded shares of DLH (NASDAQ:DLHC) from a hold rating to a buy rating in a research note published on Thursday morning. Zacks Investment Research currently has $6.50 target price on the business services provider’s stock.
According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “
A number of other analysts also recently issued reports on DLHC. TheStreet downgraded DLH from a b- rating to a c rating in a research report on Thursday, February 8th. ValuEngine raised DLH from a hold rating to a buy rating in a research report on Friday, March 2nd. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. DLH currently has a consensus rating of Buy and an average price target of $6.75.
DLH (NASDAQ:DLHC) last issued its quarterly earnings data on Tuesday, February 6th. The business services provider reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $30.22 million during the quarter, compared to the consensus estimate of $29.00 million. DLH had a return on equity of 10.06% and a net margin of 0.09%. research analysts anticipate that DLH will post 0.56 EPS for the current year.
In related news, major shareholder Wynnefield Partners Small Cap sold 200,000 shares of the firm’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $6.00, for a total transaction of $1,200,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William H. Alderman sold 7,150 shares of the firm’s stock in a transaction dated Monday, March 12th. The shares were sold at an average price of $5.70, for a total value of $40,755.00. Following the transaction, the director now owns 75,000 shares of the company’s stock, valued at $427,500. The disclosure for this sale can be found here. Insiders have sold a total of 234,966 shares of company stock valued at $1,402,187 over the last three months. Corporate insiders own 25.90% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP purchased a new position in DLH during the 3rd quarter valued at about $121,000. Renaissance Technologies LLC boosted its holdings in DLH by 8.9% during the 4th quarter. Renaissance Technologies LLC now owns 161,290 shares of the business services provider’s stock valued at $994,000 after acquiring an additional 13,200 shares during the period. Finally, Commonwealth Equity Services Inc purchased a new position in DLH during the 3rd quarter valued at about $2,342,000. Institutional investors own 55.53% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3302022/dlh-dlhc-upgraded-by-zacks-investment-research-to-buy.html.
DLH Company Profile
DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans? health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.